These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4071356)

  • 1. [Chromosomal changes in 20 patients with myelodysplastic disorders (preleukemias)].
    Zapata Gayón N; Cruz Mendoza AM; Pizzuto J; González Angulo A
    Sangre (Barc); 1985; 30(4-A):430-8. PubMed ID: 4071356
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytogenetic survey of sixty-one patients with preleukemic syndrome including myeloproliferative and myelodysplastic diseases.
    Palka G; Spadano A; Calabrese G; Parruti G; Guanciali Franchi P; Di Sante O; Recchia A; Di Lorenzo R; Torlontano G
    Ann Genet; 1990; 33(4):214-8. PubMed ID: 2095702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel chromosomal abnormality involving 2q37 in myeloid malignancies.
    Chen CC; Lee KD; Yang CF; Gau JP
    Ann Hematol; 2006 May; 85(5):333-4. PubMed ID: 16474975
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorescence in situ hybridization reveals closely correlated results in cytological and histological specimens of hematological neoplasias compared to conventional cytogenetics.
    Gerr H; Gadzicki D; Kreipe H; Schlegelberger B; Wilkens L
    Pathobiology; 2006; 73(6):271-9. PubMed ID: 17374964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chromosome aberrations in malignant blood diseases].
    Engel E; McKee LC; Engel-de Montmollin M
    Union Med Can; 1968 Jul; 97(7):901-6. PubMed ID: 5709532
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic and cytogenetic analyses of 99 cases of de novo myelodysplastic syndromes.
    D'Emilio A; Montaldi A; Stella M; Celli P; Guercini N; Tremul L; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):61-5. PubMed ID: 8039762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chromosomic characteristics associated with leukemia and other hemopathies in Costa Rica].
    Castro Volio I; Montero Umaña C; Jiménez Cruz G
    Rev Biol Trop; 1993 Dec; 41(3A):385-92. PubMed ID: 7701079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome instability is associated with hypodiploid clones in myelodysplastic syndromes.
    Knuutila S; Teerenhovi L; Borgström GH
    Hereditas; 1984; 101(1):19-30. PubMed ID: 6490390
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of single chromosome abnormalities in preleukemic states.
    Nowell PC; Besa EC
    Cancer Genet Cytogenet; 1989 Oct; 42(1):1-7. PubMed ID: 2790739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndromes (preleukemia).
    Koeffler HP
    Semin Hematol; 1986 Oct; 23(4):284-99. PubMed ID: 3535083
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytogenetics of preleukemia.
    Nowell PC
    Cancer Genet Cytogenet; 1982 Mar; 5(3):265-78. PubMed ID: 7039817
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromosome abnormalities in preleukemic or myelodysplastic syndromes.
    Michels VV; Hoagland HC
    Mayo Clin Proc; 1985 Aug; 60(8):555-6. PubMed ID: 3860708
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of chromosomes 4, 11, and 17 in a case of myelodysplastic syndrome.
    Ohyashiki K; Yoshida MA; Ohyashiki J; Kiyokawa M; Tsurumi N; Katsunuma H; Sandberg AA
    Cancer Genet Cytogenet; 1985 Nov; 18(3):265-73. PubMed ID: 3863700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis the clinic and cytogenetics of myelodysplastic syndrome].
    Cen L; Zhou M; Zhao YH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):668-9. PubMed ID: 17160950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromosome abnormalities in early cancers].
    Maeda S; Horio M; Kitazawa S; Sugiyama T
    Gan No Rinsho; 1988 Aug; 34(10):1264-72. PubMed ID: 3172486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelodysplastic syndrome (preleukemia)].
    Wickramanayake PD; Pallenschat J; Diehl V
    Med Klin (Munich); 1991 Mar; 86(3):157-64. PubMed ID: 2034179
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.